A detailed history of Strategic Capital Advisers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Capital Advisers, Inc. holds 14,214 shares of LLY stock, worth $11.3 Million. This represents 3.81% of its overall portfolio holdings.

Number of Shares
14,214
Previous 14,059 1.1%
Holding current value
$11.3 Million
Previous $4.03 Million 14.48%
% of portfolio
3.81%
Previous 3.07%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

BUY
$278.73 - $327.27 $43,203 - $50,726
155 Added 1.1%
14,214 $4.61 Million
Q1 2022

May 05, 2022

SELL
$234.69 - $291.66 $151,609 - $188,412
-646 Reduced 4.39%
14,059 $4.03 Million
Q4 2021

Jan 19, 2022

BUY
$224.85 - $279.04 $5,846 - $7,255
26 Added 0.18%
14,705 $4.06 Million
Q3 2021

Oct 29, 2021

BUY
$221.6 - $272.71 $240,436 - $295,890
1,085 Added 7.98%
14,679 $3.39 Million
Q2 2021

Jul 30, 2021

SELL
$180.55 - $233.54 $182,174 - $235,641
-1,009 Reduced 6.91%
13,594 $3.12 Million
Q1 2021

Apr 28, 2021

SELL
$164.32 - $212.72 $526,481 - $681,554
-3,204 Reduced 17.99%
14,603 $2.73 Million
Q4 2020

Jan 27, 2021

SELL
$130.46 - $172.63 $12,915 - $17,090
-99 Reduced 0.55%
17,807 $3.01 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $33,045 - $38,223
226 Added 1.28%
17,906 $2.65 Million
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $198,627 - $239,046
-1,456 Reduced 7.61%
17,680 $2.9 Million
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $13,690 - $16,945
-115 Reduced 0.6%
19,136 $2.65 Million
Q4 2019

Jan 27, 2020

BUY
$106.92 - $132.43 $7,698 - $9,534
72 Added 0.38%
19,251 $2.53 Million
Q3 2019

Nov 05, 2019

SELL
$106.79 - $116.16 $57,025 - $62,029
-534 Reduced 2.71%
19,179 $2.15 Million
Q2 2019

Jul 30, 2019

BUY
$110.79 - $129.32 $1.3 Million - $1.51 Million
11,713 Added 146.41%
19,713 $2.18 Million
Q1 2019

May 08, 2019

SELL
$111.31 - $131.02 $1.76 Million - $2.07 Million
-15,805 Reduced 66.39%
8,000 $1.04 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $1.16 Million - $1.3 Million
-10,969 Reduced 31.54%
23,805 $2.75 Million
Q3 2018

Oct 29, 2018

BUY
$85.86 - $107.31 $6,954 - $8,692
81 Added 0.23%
34,774 $3.73 Million
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $814,683 - $935,002
10,762 Added 44.97%
34,693 $3.36 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $1.96 Million - $2.1 Million
23,931
23,931 $2.02 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Strategic Capital Advisers, Inc. Portfolio

Follow Strategic Capital Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Capital Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Capital Advisers, Inc. with notifications on news.